I2B is a small cytosolic protein that participates in vacuole fusion

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5582-7. doi: 10.1073/pnas.94.11.5582.

Abstract

Saccharomyces cerevisiae vacuole inheritance requires two low molecular weight activities, LMA1 and LMA2. LMA1 is a heterodimer of thioredoxin and protease B inhibitor 2 (I2B). Here we show that the second low molecular weight activity (LMA2) is monomeric I2B. Though LMA2/I2B was initially identified as a protease B inhibitor, this protease inhibitor activity is not related to its ability to promote vacuole fusion: (i) Low Mr protease B inhibitors cannot substitute for LMA1 or LMA 2, (ii) LMA1 and LMA2 promote the fusion of vacuoles from a strain that has no protease B, (iii) low concentrations of LMA2 that fully inhibit protease B do not promote vacuole fusion, and (iv) LMA1, in which I2B is complexed with thioredoxin, is far more active than LMA2/I2B in promoting vacuole fusion and far less active in inhibiting protease B. These studies establish a new function for I2B.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chromatography, Gel
  • Cloning, Molecular
  • Cytosol / physiology
  • Dimerization
  • Escherichia coli
  • Glycoproteins / chemistry
  • Glycoproteins / isolation & purification
  • Glycoproteins / metabolism*
  • Kinetics
  • Membrane Fusion
  • Protease Inhibitors / metabolism*
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism
  • Saccharomyces cerevisiae / physiology*
  • Thioredoxins / chemistry
  • Thioredoxins / isolation & purification
  • Thioredoxins / metabolism*
  • Vacuoles / physiology*

Substances

  • Glycoproteins
  • Protease Inhibitors
  • Recombinant Proteins
  • yeast proteinase B inhibitor
  • Thioredoxins